Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

KPMG hires two tax managing directors to strengthen its alternative investment funds practice

Wednesday, March 06, 2013
Opalesque Industry Update: KPMG LLP, the U.S. audit, tax and advisory firm, is adding more depth to its Alternative Investment Funds (AIF) practice by adding two federal tax managing directors to its Los Angeles and New York offices.

“KPMG is continuing to invest in and expand its Alternative Investments team to serve its private equity, hedge funds and real estate funds clients,” said Chuck Walker, national partner in charge, Alternative Investment Funds –Tax. “We are thrilled to announce the latest managing directors to join us as we continue to strengthen our team with some of the best talent out there.”

The new hires include:

Nancy Chan, Managing Director, Federal Tax, Los Angeles

With more than 25 years of financial services experience, including an earlier role with KPMG, Chan will help to expand the Alternative Investment Funds practice in the Los Angeles market. Most recently, Chan was with Hellman and Friedman, a private equity firm, where she served as tax director. In that role she was responsible for tax planning and research, as well as participation in tax issues relating to acquisitions, restructuring, and tax audits.

Before that, Chan was a financial services executive director for asset management at Ernst and Young, providing services to hedge funds as well as private equity clients. Prior to that, she was a senior manager in KPMG’s Federal Tax practice.

Nader Karimi, Managing Director, Federal Tax, Asset Management, New York

With his extensive financial services experience, Karimi will focus on expanding relationships with and serving hedge fund and private equity clients in a variety of areas, including the implementation of the Foreign Account Tax Compliance Act (FATCA). Karimi joins KPMG from Goldman Sachs Fund Services, where he was the global head of tax and product development, supporting hedge fund and private equity clients. Previously, he was the assistant vice president and global tax manager at HSBC Security Services. Karimi also served as a project manager and an international tax consultant at Investors Bank and Trust, as well as a senior associate and business planning consultant at Barclays Global Investors in Tokyo and San Francisco.

KPMG

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its